Xeris Biopharma Holdings has appointed Ricki Fairley to its Board of Directors.
Fairley currently serves as co-founder and CEO of TOUCH, The Black Breast Cancer Alliance and is also co-host for The Doctor Is In, a weekly live breast cancer advocacy web series
Fairley has over 35 years of marketing experience including 20 years in brand management at Johnson & Johnson, Nabisco, Reckitt & Colman and The Coca-Cola Company, and over 15 years in agency leadership encompassing strategic planning and consulting for numerous Fortune 500 companies.
Xeris chairman and CEO, Paul R. Edick, said:
“On behalf of our Board, we welcome Ricki and her wealth of insights and experiences, especially her passion for advocating on behalf of patient.
“As a seasoned marketer with 35+ years in brand management and strategic planning, we look forward to collaborating with Ricki to advance our mission of serving patient communities.”
Xeris is a biopharmaceutical company aiming to improve patients’ lives by developing and commercialising innovative products across a range of therapies.
The company has three commercially available products: Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; Keveyis, a proven therapy for primary periodic paralysis; and Recorle for the treatment of endogenous Cushing’s syndrome.
It has a diverse pipeline of development and partnered programmes using its formulation sciences, XeriSol and XeriJect, to support long-term product development.
Ricki Fairley said:
“I am thrilled to join this board of astute business strategists.
“I look forward to bringing my patient advocate voice to the company’s passionate and committed pursuit of changing patients’ lives.”
